Glomax Pharma Private Limited - Company Profile

It is a business services private limited company based in New Delhi, Delhi, India, established in 2009.
2009 New Delhi, Delhi, India Struck Off
Last Updated:
Access Report
About Glomax Pharma Private Limited

Glomax Pharma Private Limited, a struck off private limited company, was established on 02 April 2009 in New Delhi, Delhi, India. Engaging in miscellaneous business activities within the business services sector, it holds CIN: U74999DL2009PTC189117. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Sanjay Pal Singh (Additional Director), Habib Ullah Mir (Additional Director). Past directors included Archana Mishra, Devendra Kumar Mishra. Its latest AGM occurred on 28 September 2011, with the balance sheet filed on 31 March 2011. It is based at F-307,Ashish Complex, Mayur Vihar Phase-I, New Delhi, Delhi, 110091.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999DL2009PTC189117

  • Registration Number

    189117

  • Incorporation Date

    02 April 2009

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 16 Year, 11 Months
  • Last Filing with ROC 31 Mar 2011
Company report

Glomax Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Glomax Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Glomax Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Sanjay Pal Singh Additional Director 29 Dec 2010 Current
Habib Ullah Mir Additional Director 29 Dec 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 17 Jan 2011 Past
Pramod Abcsdd Director 17 Jan 2011 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Glomax Pharma.

Enhance accessibility to Glomax Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Glomax Pharma revenue growth over time
Glomax Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Glomax Pharma?

Unlock access to Glomax Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Glomax Pharma?

Unlock and access historical data on people associated with Glomax Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Glomax Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Glomax Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Glomax Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Glomax Pharma Private Limited last Annual general meeting of members was held on 28 Sep 2011 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Glomax Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2011 with Roc Delhi. was recorded as a recent event.

  • Director Appointment

    Progress on Sanjay Pal Singh was appointed as a Additional Director was appointed as a Additional Director on 29 Dec 2010 & has been associated with this company since 15 years 2 months . was documented.

  • Director Appointment

    The activity Habib Ullah Mir was appointed as a Additional Director was appointed as a Additional Director on 29 Dec 2010 & has been associated with this company since 15 years 2 months . was completed.

  • Company Incorporation

    The activity Glomax Pharma Private Limited was registered on 02 Apr 2009 with Roc Delhi & aged 16 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Glomax Pharma Private Limited?

The CIN of Glomax Pharma Private Limited is U74999DL2009PTC189117.

Where is Glomax Pharma Private Limited headquartered?

Glomax Pharma Private Limited is headquartered at F-307,Ashish Complex, Mayur Vihar Phase-I, New Delhi, Delhi, 110091.

When was Glomax Pharma Private Limited incorporated?

Glomax Pharma Private Limited was incorporated on 02 April 2009.

Who are the current directors of Glomax Pharma Private Limited?

The current directors of Glomax Pharma Private Limited are

What is the primary industry of Glomax Pharma Private Limited?

The primary industry of Glomax Pharma Private Limited is Business Services.

Is Glomax Pharma Private Limited a listed company?

Glomax Pharma Private Limited is unlisted.

What is the capital structure of Glomax Pharma Private Limited?

The authorized capital of Glomax Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available